# OnCo record imnn-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/imnn-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "imnn-001" ;
  schema:name "IMNN-001"@en ;
  schema:alternateName "GEN-1"@en ;
  schema:description "IMNN-001 is an experimental interleukin-12 DNA plasmid immunotherapy from Imunon, in phase 3 trials for advanced epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer."@en ;
  schema:url <https://onco.cc/drugs/imnn-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://imunon.com/pipeline/>, <https://imunon.com/pipeline/>, <https://clinicaltrials.gov/api/v2/studies/NCT06915025>, <https://clinicaltrials.gov/search?intr=IMNN-001> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Interleukin-12 DNA plasmid immunotherapy (TheraPlas lipopolymer)" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:companies <https://onco.cc/companies/imunon/> ;
  onco:trials <https://onco.cc/trials/nct06915025/>, <https://onco.cc/trials/nct03393884/>, <https://onco.cc/trials/nct05739981/>, <https://onco.cc/trials/nct02480374/> .